News | Radiation Therapy | December 23, 2016

Scientists Investigate Cancer Radiotherapy to Make Improvements

A University of Rochester Medical Center study shows that when tumors are treated with radiotherapy, the benefits can be hijacked by the treatment's counteraction to trigger inflammation and dampen the body's immune response.

Published by the journal Oncotarget, the study suggests that radiotherapy (also known as radiation treatment) could be more effective if it was combined with a drug that would block a specific cell that is responsible for dulling the immune system. In mice, the research team experimented by delivering an immunotherapy two days prior to radiotherapy and saw significant benefits for many different types of cancer.

Led by Scott A. Gerber, Ph.D., assistant professor in the Department of Surgery, and graduate student Kelli A. Connolly, the research fills an important gap in knowledge. Scientists already know that radiotherapy stimulates anti-tumor cells and helps to control cancer's growth. What is less understood is why radiotherapy cannot cure cancer.

The answer may lie with how the immune system responds to radiotherapy when a tumor is present. The URMC and Wilmot Cancer Institute scientists discovered that radiation increases the circulation of certain harmful inflammatory cells and changes the way the immune system rallies against cancer. In many patients, the circulating level of these cells (called monocytes) is already high prior to cancer treatment and sometimes indicates a poor prognosis.

Gerber believes that the abundance of these cells, which can be measured in a simple blood test, could identify patients who might benefit most from blocking them, allowing the immune system to fight the disease in combination with radiotherapy. Because these inflammatory cells express a unique protein on their surface, they are an easy target for medications, the study said. "Our observations of what happens during radiotherapy when cells are recruited to the tumor site and surrounding tissue has intriguing implications for how to improve treatment," said Gerber, who also has an appointment in the URMC Department of Microbiology and Immunology.

For more information: www.urmc.rochester.edu

Related Content

metastatic colorectal cancer, mCRC, Sirtex, NCCN guidelines, Y-90 microspheres
News | Radiation Therapy | January 03, 2017
Sirtex Medical Limited announced in December that SIR-Spheres Y-90 resin microspheres have been included as a Category...
radiation therapy complications with implant reconstruction, autologous reconstruction
News | Radiation Therapy | January 02, 2017
January 2, 2017 — Radiotherapy increased complications and impaired patient-reported satisfaction with reconstructed
prostate, CT scan
News | Prostate Cancer | December 22, 2016
Cancer Targeted Technology (CTT), a privately-held Seattle-based biotechnology firm focusing on cancer diagnostics and...
Somatom Confidence RT Pro, RT, radiation therapy, treatment planning
Technology | Treatment Planning | December 20, 2016
December 20, 2016 — The U.S.
MR-HIFU, ThermoDox, combination therapy, recurrent childhood tumors, Celsion, Children's National Health System, Phase I clinical study
News | Oncology Related Products | December 19, 2016
December 19, 2016 — Children’s National Health System and Celsion Corp.
ASTRO, Elekta, RO-ILS, Radiation Oncology Incident Learning System, dose safety
News | Radiation Therapy | December 13, 2016
The American Society for Radiation Oncology (ASTRO) announced in November that Elekta has provided signficant financial...
radiotherapy
News | Radiation Therapy | November 22, 2016
RAD Technology Medical Systems (RAD) is adding two new patents to its portfolio of modular building technologies for...
Breast brachytherapy, partial breast irratiation

Accelerated Partial Breast Irradiation (APBI) brachytherapy for breast cancer. Image courtesy of Elekta.

 

News | Radiation Therapy | November 22, 2016
The American Society for Radiation Oncology (ASTRO) today announced an update to its Evidence-Based Consensus Statement...
Sponsored Content | Videos | Radiation Therapy | November 18, 2016
Accuray recently unveiled the company’s newest innovation, the Radixact Treatment Delivery System, a uniquely smart,...
Overlay Init